Literature DB >> 1019145

Adequate individualized dosages (AID) in perspective.

J C Maerz.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 1019145      PMCID： PMC1863620     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  8 in total

1.  Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine.

Authors:  P L Man; C H Chen
Journal:  Psychosomatics       Date:  1973 Jan-Feb       Impact factor: 2.386

2.  Strategies for the treatment of acute psychosis.

Authors:  W H Anderson; J C Kuehnle
Journal:  JAMA       Date:  1974-09-30       Impact factor: 56.272

3.  Rapid control of psychotic excitement states with intramuscular haloperidol.

Authors:  F Sangiovanni; M A Taylor; R Abrams; P Gaztanaga
Journal:  Am J Psychiatry       Date:  1973-10       Impact factor: 18.112

4.  Tardive dyskinesia. A persistent neurological syndrome associated with antipsychotic drug use.

Authors:  B C Schiele; D Gallant; G Simpson; E A Gardner; J O Cole
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

5.  End of a back ward: the rapid rehabilitation and release of chronically hospitalized psychiatric patients.

Authors:  J S Howard; K T Schmidt
Journal:  Psychosomatics       Date:  1973 Nov-Dec       Impact factor: 2.386

6.  Withdrawal of antiparkinson drugs.

Authors:  P Orlov; G Kasparian; A DiMascio; J O Cole
Journal:  Arch Gen Psychiatry       Date:  1971-11

7.  The management of excitement in a general hospital psychiatric ward by high dosage haloperidol.

Authors:  A J Oldham; M Bott
Journal:  Acta Psychiatr Scand       Date:  1971       Impact factor: 6.392

8.  Antiparkinson drugs as causal agents in tardive dyskinesia.

Authors:  L G Kiloh; J S Smith; S E Williams
Journal:  Med J Aust       Date:  1973-09-22       Impact factor: 7.738
  8 in total
  1 in total

1.  High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.

Authors:  N Bjørndal; M Bjerre; J Gerlach; P Kristjansen; G Magelund; I H Oestrich; J Waehrens
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.